IR
Superintel
Overview
Markets
Watchlist
More
Navidea Biopharmaceuticals I (NAVBQ)
Q3 2025 vs Q4 2025
Comparing institutional holders between quarters
Quarters
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
All
Compare
Detailed
Historical
Funds
Options
Short Interest
13D/13G
Peers
Targeting
Trading Summary
Profile
2
Filed
1
New
0
Closed
0
Increased
0
Decreased
1
Unchanged
0
No Data
Sort by
Q4 2025 shares — high to low
Q4 2025 shares — low to high
Share change — largest gain
Share change — largest cut
% change — largest gain
% change — largest cut
Q4 2025 value — high to low
Value change — largest gain
Value change — largest cut
Institution — A to Z
Filed — newest first
Front Row Advisors LLC
NEW
Shares
280
Change
+280
Value
$0
Filed 2026-02-12
Ancora Advisors LLC
A
UNCHANGED
Shares
100
from 100
Change
0
(0%)
Value
$0
($0)
Filed 2026-02-17
Institution
Status
Q4 2025 ↓
Q3 2025
Change
% Change
Q3 2025 Value
Q4 2025 Value
Value Change
Filed
Front Row Advisors LLC
NEW
280
—
+280
—
—
$0
—
2026-02-12
Ancora Advisors LLC
A
UNCHANGED
100
100
0
0%
$0
$0
$0
2026-02-17
Showing 2 of 2 institutions